Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guidez, F.
Right arrow Articles by Zelent, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guidez, F.
Right arrow Articles by Zelent, A.
Related Collections
Right arrow Neoplasia
Right arrow Oncogenes and Tumor Suppressors
Right arrow Gene Expression
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 October 2000, Vol. 96, No. 7, pp. 2557-2561

NEOPLASIA

Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein

Fabien Guidez, Kevin Petrie, Anthony M. Ford, Huafeng Lu, Caroline A. Bennett, Angus MacGregor, Jürgen Hannemann, Yoshiaki Ito, Jacques Ghysdael, Mel Greaves, Leanne M. Wiedemann, and Arthur Zelent

From the Leukaemia Research Fund Centre at the Institute of Cancer Research, Chester Beatty Laboratories, London, England; the Department of Viral Oncology, Institute of Virus Research, Kyoto University, Kyoto, Japan; and the CNRS UMR 146, Institut Curie, Section de Recherche, Centre Universitaire, Orsay, France.

The t(12;21)(p13;q22) chromosomal translocation is the most frequent illegitimate gene recombination in a pediatric cancer and occurs in approximately 25% of common acute lymphoblastic leukemia (cALL) cases. This rearrangement results in the in frame fusion of the 5'-region of the ETS-related gene, TEL (ETV6), to almost the entire acute myeloid leukemia 1 (AML1) (also called CBFA2 or PEBP2AB1) locus and expression of the TEL-AML1 chimeric protein. Although AML1 stimulates transcription, TEL-AML1 functions as a repressor of some AML1 target genes. In contrast to the wild type AML1 protein, both TEL and TEL-AML1 interact with N-CoR, a component of the nuclear receptor corepressor complex with histone deacetylase activity. The interaction between TEL and N-CoR requires the central region of TEL, which is retained in TEL-AML1, and TEL lacking this domain is impaired in transcriptional repression. Taken together, our results suggest that TEL-AML1 may contribute to leukemogenesis by recruiting N-CoR to AML1 target genes and thus imposing an altered pattern of their expression.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
L. Roudaia, M. D. Cheney, E. Manuylova, W. Chen, M. Morrow, S. Park, C.-T. Lee, P. Kaur, O. Williams, J. H. Bushweller, et al.
CBF{beta} is critical for AML1-ETO and TEL-AML1 activity
Blood, March 26, 2009; 113(13): 3070 - 3079.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. Ghisletti, W. Huang, K. Jepsen, C. Benner, G. Hardiman, M. G. Rosenfeld, and C. K. Glass
Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways
Genes & Dev., March 15, 2009; 23(6): 681 - 693.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-N. Song and E. P. Gelmann
Silencing Mediator for Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Attenuate Transcriptional Activation by the {beta}-Catenin-TCF4 Complex
J. Biol. Chem., September 19, 2008; 283(38): 25988 - 25999.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Fazio, C. Palmi, A. Rolink, A. Biondi, and G. Cazzaniga
PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI Cells
Cancer Res., January 1, 2008; 68(1): 181 - 189.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Guidez, S. Parks, H. Wong, J. V. Jovanovic, A. Mays, A. F. Gilkes, K. I. Mills, M.-C. Guillemin, R. M. Hobbs, P. P. Pandolfi, et al.
RAR{alpha}-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia
PNAS, November 20, 2007; 104(47): 18694 - 18699.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Starkova, J. Madzo, G. Cario, T. Kalina, A. Ford, M. Zaliova, O. Hrusak, and J. Trka
The Identification of (ETV6)/RUNX1-Regulated Genes in Lymphopoiesis Using Histone Deacetylase Inhibitors in ETV6/RUNX1-Positive Lymphoid Leukemic Cells
Clin. Cancer Res., March 15, 2007; 13(6): 1726 - 1735.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Blaschke, Y. Takata, E. Caglayan, A. Collins, P. Tontonoz, W. A. Hsueh, and R. K. Tangirala
A Nuclear Receptor Corepressor-Dependent Pathway Mediates Suppression of Cytokine-Induced C-Reactive Protein Gene Expression by Liver X Receptor
Circ. Res., December 8, 2006; 99(12): e88 - e99.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
X. Zhang, Y. Ozawa, H. Lee, Y.-D. Wen, T.-H. Tan, B. E. Wadzinski, and E. Seto
Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4
Genes & Dev., April 1, 2005; 19(7): 827 - 839.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Eguchi, M. Eguchi-Ishimae, A. Green, T. Enver, and M. Greaves
Directing oncogenic fusion genes into stem cells via an SCL enhancer
PNAS, January 25, 2005; 102(4): 1133 - 1138.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Ogawa, J. Lozach, K. Jepsen, D. Sawka-Verhelle, V. Perissi, R. Sasik, D. W. Rose, R. S. Johnson, M. G. Rosenfeld, and C. K. Glass
A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation
PNAS, October 5, 2004; 101(40): 14461 - 14466.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Schick, E. J. Oakeley, N. E. Hynes, and A. Badache
TEL/ETV6 Is a Signal Transducer and Activator of Transcription 3 (Stat3)-induced Repressor of Stat3 Activity
J. Biol. Chem., September 10, 2004; 279(37): 38787 - 38796.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. W. So and M. L. Cleary
Dimerization: a versatile switch for oncogenesis
Blood, August 15, 2004; 104(4): 919 - 922.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. Asakura, H. Uchida, H. Miyachi, H. Kobayashi, Y. Miyakawa, S. D. Nimer, H. Takahashi, Y. Ikeda, and M. Kizaki
TEL/AML1 Overcomes Drug Resistance Through Transcriptional Repression of Multidrug Resistance-1 Gene Expression
Mol. Cancer Res., June 1, 2004; 2(6): 339 - 347.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Tsuzuki, M. Seto, M. Greaves, and T. Enver
Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice
PNAS, June 1, 2004; 101(22): 8443 - 8448.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Maki, H. Arai, K. Waga, K. Sasaki, F. Nakamura, Y. Imai, M. Kurokawa, H. Hirai, and K. Mitani
Leukemia-Related Transcription Factor TEL Is Negatively Regulated through Extracellular Signal-Regulated Kinase-Induced Phosphorylation
Mol. Cell. Biol., April 15, 2004; 24(8): 3227 - 3237.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Irvin, L. D. Wood, L. Wang, R. Fenrick, C. G. Sansam, G. Packham, M. Kinch, E. Yang, and S. W. Hiebert
TEL, a Putative Tumor Suppressor, Induces Apoptosis and Represses Transcription of Bcl-XL
J. Biol. Chem., November 21, 2003; 278(47): 46378 - 46386.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. G. Lopez, C. Carron, and J. Ghysdael
v-SRC Specifically Regulates the Nucleo-cytoplasmic Delocalization of the Major Isoform of TEL (ETV6)
J. Biol. Chem., October 17, 2003; 278(42): 41316 - 41325.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. K. Mann, A. Rephaeli, A. L. Colosimo, Z. Diaz, A. Nudelman, I. Levovich, Y. Jing, S. Waxman, and W. H. Miller Jr.
A Retinoid/Butyric Acid Prodrug Overcomes Retinoic Acid Resistance in Leukemias by Induction of Apoptosis
Mol. Cancer Res., October 1, 2003; 1(12): 903 - 912.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Tomita, D. R. Buchholz, K. Obata, and Y.-B. Shi
Fusion Protein of Retinoic Acid Receptor {alpha} with Promyelocytic Leukemia Protein or Promyelocytic Leukemia Zinc Finger Protein Recruits N-CoR-TBLR1 Corepressor Complex to Repress Transcription in Vivo
J. Biol. Chem., August 15, 2003; 278(33): 30788 - 30795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Petrie, F. Guidez, L. Howell, L. Healy, S. Waxman, M. Greaves, and A. Zelent
The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms
J. Biol. Chem., April 25, 2003; 278(18): 16059 - 16072.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. D. Wood, B. J. Irvin, G. Nucifora, K. S. Luce, and S. W. Hiebert
Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor
PNAS, March 18, 2003; 100(6): 3257 - 3262.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. L. Durst, B. Lutterbach, T. Kummalue, A. D. Friedman, and S. W. Hiebert
The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain
Mol. Cell. Biol., January 15, 2003; 23(2): 607 - 619.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
W. L. Carroll, D. Bhojwani, D.-J. Min, E. Raetz, M. Relling, S. Davies, J. R. Downing, C. L. Willman, and J. C. Reed
Pediatric Acute Lymphoblastic Leukemia
Hematology, January 1, 2003; 2003(1): 102 - 131.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. T. Maia, A. M. Ford, G. R. Jalali, C. J. Harrison, G. M. Taylor, O. B. Eden, and M. F. Greaves
Molecular tracking of leukemogenesis in a triplet pregnancy
Blood, July 15, 2001; 98(2): 478 - 482.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020